These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24163048)

  • 1. Costs of current antihypertensive therapy in Switzerland: an economic evaluation of 3,489 patients in primary care.
    Schäfer HH; Scheunert U
    Swiss Med Wkly; 2013; 143():w13854. PubMed ID: 24163048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive pharmacotherapy of patients in primary care with either a statutory or private health insurance].
    Laux G; Szecsenyi J; Miksch A; Grün B; Gutscher A; Grün B; Rosemann T; Kühlein T
    Med Klin (Munich); 2009 Feb; 104(2):108-13. PubMed ID: 19242661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of prescription antihypertensive drug utilization and adherence to treatment guidelines in the city of Novi Sad.
    Tomas A; Tomić Z; Milijasević B; Ban M; Horvat O; Vukmirović S; Sabo A
    Vojnosanit Pregl; 2016 Jun; 73(6):531-7. PubMed ID: 27498444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment adherence, clinical outcomes, and economics of triple-drug therapy in hypertensive patients.
    Panjabi S; Lacey M; Bancroft T; Cao F
    J Am Soc Hypertens; 2013; 7(1):46-60. PubMed ID: 23321404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical treatment of hypertension in Switzerland. The 2009 Swiss Hypertension Survey (SWISSHYPE).
    Brenner R; Waeber B; Allemann Y
    Swiss Med Wkly; 2011; 141():w13169. PubMed ID: 21374529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
    Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
    Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care.
    Mazzaglia G; Mantovani LG; Sturkenboom MC; Filippi A; Trifirò G; Cricelli C; Brignoli O; Caputi AP
    J Hypertens; 2005 Nov; 23(11):2093-100. PubMed ID: 16208153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
    Baser O; Andrews LM; Wang L; Xie L
    J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmaco-economic aspects of the treatment of hypertension].
    Delporte JP; Rorive G
    Rev Med Liege; 1998 May; 53(5):259-64. PubMed ID: 9689879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
    Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
    Dickson M; Plauschinat CA
    Am J Cardiovasc Drugs; 2008; 8(1):45-50. PubMed ID: 18303937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of single-pill and separate-pill administration of antihypertensive triple combination therapy: a population-based microsimulation study.
    Morabito G; Gregorio C; Ieva F; Barbati G; Mancia G; Corrao G; Rea F
    BMC Public Health; 2024 Jul; 24(1):1808. PubMed ID: 38971775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the phamacologic treatment of hypertension in the Department of Veterans Affairs 1997-1999: decreased use of calcium antagonists and increased use of beta-blockers and thiazide diuretics.
    Siegel D; Lopez J; Meier J; Cunningham F
    Am J Hypertens; 2001 Sep; 14(9 Pt 1):957-62. PubMed ID: 11587164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker.
    Okano GJ; Rascati KL; Wilson JP; Remund DD; Grabenstein JD; Brixner DI
    Clin Ther; 1997; 19(6):1433-45; discussion 1424-5. PubMed ID: 9444451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive drugs for elderly patients: a cross- sectional study.
    Lim KK; Sivasampu S; Khoo EM
    Singapore Med J; 2015 May; 56(5):291-7. PubMed ID: 25597751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The costs of treatment of hypertension in Switzerland and worldwide.
    Rutishauser WJ
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):931-3. PubMed ID: 2577286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
    Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An economic evaluation of the JNC hypertension guidelines using data from a randomized controlled trial. Joint National Committee.
    Ramsey SD; Neil N; Sullivan SD; Perfetto E
    J Am Board Fam Pract; 1999; 12(2):105-14. PubMed ID: 10220232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive drug treatment changes in the general population: the CoLaus study.
    Christe V; Waeber G; Vollenweider P; Marques-Vidal P
    BMC Pharmacol Toxicol; 2014 Mar; 15():20. PubMed ID: 24685255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.
    Park C; Wang G; Durthaler JM; Fang J
    Am J Prev Med; 2017 Dec; 53(6S2):S131-S142. PubMed ID: 29153114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.